AccScience Publishing / GTM / Online First / DOI: 10.36922/GTM025510094
REVIEW ARTICLE

Pharmacological and toxicological perspectives of bioactive peptides

Adel Ghorani-Azam1,2 Sina Karimipour3 Samaneh Sepahi2,4*
Show Less
1 Department of Forensic Medicine and Toxicology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran
2 Food and Drug Research Center, Food and Drug Administration, Ministry of Health and Medical Education, Tehran, Iran
3 Laser Applications in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Food and Beverages Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran
Global Translational Medicine, 025510094 https://doi.org/10.36922/GTM025510094
Received: 16 December 2025 | Revised: 23 March 2026 | Accepted: 23 April 2026 | Published online: 12 May 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract

Bioactive peptides, from dietary and environmental sources, represent a promising front line for developing pharmaceuticals, functional foods, and a new generation of antibiotics. However, their therapeutic application necessitates a comprehensive understanding of their mechanisms of action and toxicological profile. Peptides exhibit effective mechanisms in combating bacterial infections and cancer therapy. However, findings reveal significant toxicological concerns, hemolytic activity, immunogenic reactions, and instability in the cellular environment that can lead to unpredictable metabolic byproducts. Furthermore, the dose and source of peptides are critical determinants of their safety and efficacy. Accordingly, the dual nature of bioactive peptides necessitates a balanced approach to enhance their efficacy while minimizing their potential harm. For these purposes, peptide-specific toxicological screening is essential for translating these natural compounds into safe and effective therapeutic agents. The purpose of this article is to comprehensively review the potential applications of bioactive peptides, their pharmacological mechanisms, and toxicological profiles to elucidate their efficacy and safety for use in food and medicine.

Keywords
Natural peptides
Toxicology
Pharmacology
Food-derived peptides
Peptide drugs
Bioactive peptides
Funding
None.
Conflict of interest
The authors declare that they have no competing interests.
References
  1. Yun YH, Yoon H, Park E. Association of health asset value with subjective well-being, depression, health management strategy and habits in South Korea. Sci Rep. 2022;12(1). doi: 10.1038/s41598-022-23099-8
  2. Zakir SK, Jawed B, Esposito JE, et al. The Role of Peptides in Nutrition: Insights into Metabolic, Musculoskeletal, and Behavioral Health: A Systematic Review. Int J Mol Sci. 2025;26(13):6043. doi: 10.3390/ijms26136043
  3. Asoodeh A, Azam AG, Chamani J. Identification and Characterization of Novel Antibacterial Peptides from Skin Secretions of Euphlyctis cyanophlyctis. Int J Pept Res Ther. 2011;18(2):107-115. doi: 10.1007/s10989-011-9284-6
  4. Ghorani-Azam A, Balali-Mood M, Aryan E, Karimi G, Riahi-Zanjani B. Effect of amino acid substitution on biological activity of cyanophlyctin-β and brevinin-2R. J Mol Struct. 2018;1158:14-18. doi: 10.1016/j.molstruc.2018.01.015
  5. Asoodeh A, Sepahi S, Ghorani‐Azam A. Purification and Modeling Amphipathic Alpha Helical Antimicrobial Peptides from Skin Secretions of Euphlyctis cyanophlyctis. Chem Biol Drug Des. 2014;83(4):411-417. doi: 10.1111/cbdd.12256
  6. Yami HA, Tahmoorespur M, Javadmanesh A, Tazarghi A, Sekhavati MH. The immunomodulatory effects of lactoferrin and its derived peptides on NF-kappaB signaling pathway: A systematic review and meta-analysis. Immun Inflamm Dis. 2023;11(8):e972. doi: 10.1002/iid3.972
  7. Hamadou M. Bioactive peptides and metabolic health: a mechanistic review of the impact on insulin sensitivity, lipid profiles, and inflammation. Appl Food Res. 2025;5(2):101056. doi: 10.1016/j.afres.2025.101056
  8. Al Tahan MA, Al-Khattawi A, Russell C. Oral peptide delivery Systems: Synergistic approaches using polymers, lipids, Nanotechnology, and needle-based carriers. J Drug Deliv Sci Technol. 2025;112:107205. doi: 10.1016/j.jddst.2025.107205
  9. Vecchio I, Tornali C, Bragazzi NL, Martini M. The Discovery of Insulin: An Important Milestone in the History of Medicine. Front Endocrinol. 2018;9:613. doi: 10.3389/fendo.2018.00613
  10. Zheng B, Wang X, Guo M, Tzeng C-M. Therapeutic Peptides: Recent Advances in Discovery, Synthesis, and Clinical Translation. Int J Mol Sci 2025;26(11):5131. doi: 10.3390/ijms26115131
  11. Rossino G, Marchese E, Galli G, et al. Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era. Molecules. 2023;28(20):7165. doi: 10.3390/molecules28207165
  12. Wang K, Mwangi J, Cao K, et al. Peptide Toxin Diversity and a Novel Antimicrobial Peptide from the Spider Oxyopes forcipiformis. Toxins. 2024;16(11):466. doi: 10.3390/toxins16110466
  13. Vidya V, Achar RR, M UH, et al. Venom peptides - A comprehensive translational perspective in pain management. Curr Res Tox. 2021;2:329-340. doi: 10.1016/j.crtox.2021.09.001
  14. Rady I, Siddiqui IA, Rady M, Mukhtar H. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett. 2017;402:16-31. doi: 10.1016/j.canlet.2017.05.010
  15. Fajloun Z, Roufayel R, Rima M. Animal Venoms for Drug Discovery: A Constantly Evolving Research Field. Toxins. 2026;18(1):30. doi: 10.3390/toxins18010030
  16. daCosta CJB, Free CR, Sine SM. Stoichiometry for α-bungarotoxin block of α7 acetylcholine receptors. Nat Commun. 2015;6(1). doi: 10.1038/ncomms9057
  17. Li R, Yu J, Ye D, et al. Conotoxins: Classification, Prediction, and Future Directions in Bioinformatics. Toxins. 2025;17(2):78. doi: 10.3390/toxins17020078
  18. Huang Y, Kamau PM, Wang J, Gao M, Li B. Scorpion Venom Neurotoxins: Molecular Diversity, Mechanisms, and Drug Scaffolds. Toxins. 2026;18(1):25. doi: 10.3390/toxins18010025
  19. Baindara P. Antimicrobial Peptides: An Emerging Hope in the Era of New Infections and Resistance. Antibiotics. 2025;14(6):546. doi: 10.3390/antibiotics14060546
  20. Bhangu SK, Welch N, Lewis M, et al. Machine Learning‐ Assisted Prediction and Generation of Antimicrobial Peptides. Small Sci. 2025;5(6). doi: 10.1002/smsc.202400579
  21. Russell FE. Pressure and immobilization for snakebite remains speculative. Ann Emerg Med. 1982;11(12):701-2. doi: 10.1016/s0196-0644(82)80277-1
  22. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA. 1987;84(15):5449-5453. doi: 10.1073/pnas.84.15.5449
  23. Imura Y, Choda N, Matsuzaki K. Magainin 2 in action: distinct modes of membrane permeabilization in living bacterial and mammalian cells. Biophys J. 2008;95(12):5757- 5765. doi: 10.1529/biophysj.108.133488
  24. Matejuk A, Leng Q, Begum MD, et al. Peptide-based Antifungal Therapies against Emerging Infections. Drugs Future. 2010;35(3):197. doi: 10.1358/dof.2010.035.03.1452077
  25. Shin JM, Gwak JW, Kamarajan P, Fenno JC, Rickard AH, Kapila YL. Biomedical applications of nisin. J Appl Microbiol. 2016;120(6):1449-65. doi: 10.1111/jam.13033
  26. Younes M, Aggett P, et al. Safety of nisin (E 234) as a food additive in the light of new toxicological data and the proposed extension of use. EFSA J. 2017;15(12):e05063. doi: 10.2903/j.efsa.2017.5063
  27. Hsiao Y-C, Yamada M. The Roles of Peptide Hormones and Their Receptors during Plant Root Development. Genes. 2020;12(1):22. doi: 10.3390/genes12010022
  28. Li X, Zhu L, Wang H, et al. Peptide Hormone-Mediated Regulation of Plant Development and Environmental Adaptability. Adv Sci. 2025;12(34):e06590. doi: 10.1002/advs.202506590
  29. English A, Irwin N. Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions. Cell Mol Life Sci. 2019;12. doi: 10.1177/1179551419888871
  30. Rehfeld JF, Friis-Hansen L, Goetze JP, Hansen TV. The biology of cholecystokinin and gastrin peptides. Curr Methods Med Chem Biol Phys. 2007;7(12):1154-1165. doi: 10.2174/156802607780960483
  31. Gallas S, Fetissov SO. Ghrelin, appetite and gastric electrical stimulation. Peptides. 2011;32(11):2283-2289. doi: 10.1016/j.peptides.2011.05.027
  32. Afroze S, Meng F, Jensen K, et al. The physiological roles of secretin and its receptor. Ann Transl Med. 2013;1(3):29. doi: 10.3978/j.issn.2305-5839.2012.12.01
  33. Poitras P, Peeters TL. Motilin. Curr Opin Endocrinol Diabetes Obes. 2008;15(1):54-57. doi: 10.1097/MED.0b013e3282f370af
  34. Sheng JA, Bales NJ, Myers SA, et al. The Hypothalamic- Pituitary-Adrenal Axis: Development, Programming Actions of Hormones, and Maternal-Fetal Interactions. Front Behav Neurosci. 2020;14:601939. doi: 10.3389/fnbeh.2020.601939
  35. Hemat Jouy S, Mohan S, Scichilone G, Mostafa A, Mahmoud AM. Adipokines in the Crosstalk between Adipose Tissues and Other Organs: Implications in Cardiometabolic Diseases. Biomedicines. 2024;12(9):2129. doi: 10.3390/biomedicines12092129
  36. Farooqi IS, O’Rahilly S. Leptin: a pivotal regulator of human energy homeostasis. Am J Clin Nutr. 2009;89(3):980S-984S. doi: 10.3945/ajcn.2008.26788C
  37. Nishikimi T, Kato J. Cardiac Peptides-Current Physiology, Pathophysiology, Biochemistry, Molecular Biology, and Clinical Application. Biology. 2022;11(2):330. doi: 10.3390/biology11020330
  38. Borish LC, Steinke JW. Cytokines and chemokines. J Allergy Clin Immunol. 2003;111(2):S460-S475. doi: 10.1067/mai.2003.108
  39. Hagman S, Makinen A, Yla-Outinen L, Huhtala H, Elovaara I, Narkilahti S. Effects of inflammatory cytokines IFN-gamma, TNF-alpha and IL-6 on the viability and functionality of human pluripotent stem cell-derived neural cells. J Neuroimmunol. 2019;331:36-45. doi: 10.1016/j.jneuroim.2018.07.010
  40. Wang L, Wang N, Zhang W, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. 2022;7(1):48. doi: 10.1038/s41392-022-00904-4
  41. Martian PC, Tertis M, Leonte D, Hadade N, Cristea C, Crisan O. Cyclic peptides: A powerful instrument for advancing biomedical nanotechnologies and drug development. J Pharm Biomed Anal. 2025;252:116488. doi: 10.1016/j.jpba.2024.116488
  42. Sepahi S, Kiaei L, Kiaei M, Ghorani-Azam A. A systematic review of emerging technologies to enhance the treatment of ovarian cancer. Pharm Dev Technol. 2023;28(7):660-677. doi: 10.1080/10837450.2023.2233588
  43. Alqadi R, Alqumia A, Alhomoud IS, et al. Cyclosporine: Immunosuppressive effects, entwined toxicity, and clinical modulations of an organ transplant drug. Transpl Immunol. 2025;88:102147. doi: 10.1016/j.trim.2024.102147
  44. Zheng Z, Zong Y, Ma Y, et al. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9(1). doi: 10.1038/s41392-024-01931-z
  45. Souza‐Silva IM, de Paula CA, Bolais‐Ramos L, et al. Peptide fragments of bradykinin show unexpected biological activity not mediated by B1 or B2 receptors. Br J Pharmacol. 2022;179(12):3061-3077. doi: 10.1111/bph.15790
  46. Xiao W, Jiang W, Chen Z, et al. Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines. Signal Transduct Target Ther. 2025;10(1). doi: 10.1038/s41392-024-02107-5
  47. Jha SS. Biologics: Teriparatide and Newer Anabolics. Indian J Orthop. 2023;57(1):135-146. doi: 10.1007/s43465-023-01063-6
  48. Gladwell TD. Bivalirudin: a direct thrombin inhibitor. Clin Ther. 2002;24(1):38-58. doi: 10.1016/s0149-2918(02)85004-4
  49. Eiden LE, Hernandez VS, Jiang SZ, Zhang L. Neuropeptides and small-molecule amine transmitters: cooperative signaling in the nervous system. Cell Mol Life Sci. 2022;79(9):492. doi: 10.1007/s00018-022-04451-7
  50. Mains RE, Eipper BA. Peptides. In: Scott Brady GS, R. Wayne Albers, Donald L. Price ed. Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 8th ed. Academic Press Inc; 2012:390-407. doi: 10.1016/B978-0-12-374947-5.00020-1
  51. Grattan DR. 60 Years OF Neroendocrinoloty: The hypothalamo-prolactin axis. J Clin Endocrinol Metab. 2015;226(2):T101-22. doi: 10.1530/JOE-15-0213
  52. Avilés-Gaxiola S, García-Aguiar I, Jiménez-Ortega LA, Gutiérrez-Grijalva EP, Heredia JB. Bioactive Plant Peptides: Physicochemical Features, Structure-Function Insights and Mechanism of Action. Molecules. 2025;30(18):3683. doi: 10.3390/molecules30183683
  53. Mashayekhi-Sardoo H, Sepahi S, Baradaran Rahimi V, Askari VR. Application of Nigella sativa as a functional food in diabetes and related complications: Insights on molecular, cellular, and metabolic effects. J Funct Foods. 2024;122:106518. doi: 10.1016/j.jff.2024.106518
  54. Alves de Souza SM, Hernández-Ledesma B, de Souza TLF. Lunasin as a Promising Plant-Derived Peptide for Cancer Therapy. Int J Mol Sci. 2022;23(17):9548. doi: 10.3390/ijms23179548
  55. Craik DJ, Mylne JS, Daly NL. Cyclotides: macrocyclic peptides with applications in drug design and agriculture. Cell Mol Life Sci. 2010;67(1):9-16. doi: 10.1007/s00018-009-0159-3
  56. Kan M-W, Roseli RB, Chan LY, Nguyen LTT, Craik DJ. Recent progress on cyclotides: 2021-2024. ScienceAsia. 2025;51S(1). doi: 10.2306/scienceasia1513-1874.2025.s009
  57. Kadam D, Kadam A, Koksel F, Aluko RE. Plant‐derived bioactive peptides: A comprehensive review. Sustain Food Protein. 2024;2(4):183-214. doi: 10.1002/sfp2.1036
  58. Machado M, Bautista-Hérnandez I, Gómez-García R, Silva S, Costa EM. Bioactive Food Proteins: Bridging Nutritional and Functional Benefits with Sustainable Protein Sources. Foods. 2025;14(17):3035. doi: 10.3390/foods14173035
  59. Wang Z, Li Y, Fu W, Wu J. Unraveling the mechanisms of action of food-derived bioactive peptides: Insights from Omics approaches. Food Nutr. 2025;1(2):100019. doi: 10.1016/j.fnutr.2025.100019
  60. Scholz-Ahrens KE, Schrezenmeir J. Effects of bioactive substances in milk on mineral and trace element metabolism with special reference to casein phosphopeptides. Br J Nutr. 2000;84 (S1):S147-S153. doi: 10.1017/s0007114500002373
  61. Rivero-Pino F, Villanueva Á, Montserrat-de-la-Paz S, Sanchez-Fidalgo S, Millán-Linares MC. Evidence of Immunomodulatory Food-Protein Derived Peptides in Human Nutritional Interventions: Review on the Outcomes and Potential Limitations. Nutrients. 2023;15(12):2681. doi: 10.3390/nu15122681
  62. Purohit K, Reddy N, Sunna A. Exploring the Potential of Bioactive Peptides: From Natural Sources to Therapeutics. Int J Mol Sci. 2024;25(3) :1391. doi: 10.3390/ijms25031391
  63. Bidram M, Ganjalikhany MR. Bioactive peptides from food science to pharmaceutical industries: Their mechanism of action, potential role in cancer treatment and available resources. Heliyon. 2024;10(23):e40563. doi: 10.1016/j.heliyon.2024.e40563
  64. Liu M, Svirskis D, Proft T, et al. Progress in peptide and protein therapeutics: Challenges and strategies. Acta Pharm Sin B. 2025;15(12):6342-6381. doi: 10.1016/j.apsb.2025.10.026
  65. Evans BJ, King AT, Katsifis A, Matesic L, Jamie JF. Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals. Molecules. 2020;25(10):2314. doi: 10.3390/molecules25102314
  66. Desai N, Rana D, Patel M, Bajwa N, Prasad R, Vora LK. Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape. Small. 2025;21(29):e2502315. doi: 10.1002/smll.202502315
  67. Chen H, Sun J, Fang H, et al. Food-derived bioactive peptides: health benefits, structure‒activity relationships, and translational prospects. J Zhejiang Univ Sci B. 2025;26(11):1037-1058. doi: 10.1631/jzus.B2400106
Share
Back to top
Global Translational Medicine, Electronic ISSN: 2811-0021 Print ISSN: 3060-8600, Published by AccScience Publishing